Waldencast plc (WALDU) Stock Analysis
DELISTED 2022
What happened to Waldencast plc (WALDU) stock?
Waldencast plc (WALDU) no longer trades on public markets. It was delisted in July 2022. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Waldencast plc (WALDU) trades at $9.06. Waldencast plc is a skin care company that provides advanced skin care treatments. Its portfolio includes Obagi Medical and Obagi Clinical, which offer products designed to minimize signs of skin aging. Sector: Technology.
Last analyzed: Mar 17, 2026Analyst Coverage for WALDU: WALDU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WALDU against Technology peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
WALDU: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Waldencast plc (WALDU) Technology Profile & Competitive Position
Waldencast plc, operating in the technology sector, focuses on advanced skincare treatments through its Obagi Medical and Obagi Clinical brands. The company's products target anti-aging, hyperpigmentation, and skin damage, primarily distributed via dermatologists and medical spas, positioning it within the competitive skincare market.
What Is the Investment Thesis for WALDU?
Waldencast plc presents a focused investment opportunity within the skincare sector, driven by its established Obagi Medical and Obagi Clinical brands. The company's emphasis on dermatologist-recommended products and advanced formulations positions it favorably in the anti-aging and skin correction market. However, a current P/E ratio of -0.80 and a negative profit margin of -84.4% indicate challenges in achieving profitability. Key value drivers include expanding distribution channels and continued product innovation. Growth catalysts involve increasing brand awareness and leveraging digital marketing strategies. Investors should monitor the company's ability to improve its financial performance and capitalize on market demand for advanced skincare solutions.
Based on FMP financials and quantitative analysis
WALDU Key Highlights
P/E ratio of -0.80 indicates the company is currently not profitable.
- Profit Margin of -84.4% reflects significant losses relative to revenue.
- Gross Margin of 45.5% suggests a strong potential for profitability if operating expenses are managed effectively.
- The company focuses on advanced skincare treatments, targeting a specific niche within the broader skincare market.
- Waldencast's products are primarily available through dermatologists and medical spas, indicating a focus on professional channels.
Who Are WALDU's Competitors?
WALDU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| UBER Uber Technologies, Inc. | $78.55 | +0.65% | $160B | 73 |
| APP AppLovin Corporation | $308.77 | -0.65% | $104B | 95 |
| INTU Intuit Inc. | $363.10 | +0.17% | $100B | 79 |
| CDNS Cadence Design Systems, Inc. | $313.59 | -0.44% | $86.4B | 73 |
| ADSK Autodesk, Inc. | $252.25 | +0.38% | $53.3B | 77 |
| WDAY Workday, Inc. | $197.32 | -0.55% | $51.7B | 75 |
| ZM Zoom Communications, Inc. | $106.30 | -1.09% | $31.2B | 91 |
| FICO Fair Isaac Corporation | $1149.75 | -1.02% | $24.8B | 90 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WALDU's Key Strengths?
Established brands (Obagi Medical and Obagi Clinical)
- Focus on advanced skincare treatments
- Distribution through professional channels
- Scientifically-backed formulations
What Are WALDU's Weaknesses?
Negative profit margin (-84.4%)
- High operating expenses
- Limited geographic reach
- Dependence on professional distribution channels
What Could Drive WALDU Stock Higher?
Launch of new skincare products targeting specific skin concerns (2026 Q3).
- Expansion of digital marketing initiatives to increase brand awareness.
- Strategic partnerships with dermatologists and medical spas to enhance distribution.
What Are the Key Risks for WALDU?
Negative return on equity (-6.6%) — the business is not currently generating profit on shareholder capital.
- Intense competition in the skincare industry could impact market share.
- Economic downturns could reduce consumer spending on discretionary items like skincare products.
- Negative profit margin poses a risk to financial stability.
- Regulatory changes in the skincare industry could impact product development and marketing.
What Are the Growth Opportunities for WALDU?
- Expansion of Digital Marketing Channels: Waldencast plc can leverage digital marketing to reach a broader audience and increase brand awareness. Investing in targeted online advertising, social media campaigns, and influencer partnerships can drive customer acquisition and sales growth. The global digital advertising market is projected to reach $645.53 billion in 2024, offering significant opportunities for Waldencast to enhance its online presence and drive revenue growth. Timeline: Ongoing.
- Product Innovation and Development: Introducing new and innovative skincare products can attract new customers and retain existing ones. Focusing on research and development to create advanced formulations and address specific skin concerns can differentiate Waldencast from its competitors. The global cosmeceuticals market is expected to reach $67.9 billion by 2027, presenting a substantial market for new product launches. Timeline: Ongoing.
- Strategic Partnerships with Dermatologists and Medical Spas: Strengthening relationships with dermatologists and medical spas can enhance distribution and build brand credibility. Offering exclusive products or services to these partners can create a competitive advantage and drive sales. The medical spa industry is experiencing steady growth, with revenues projected to increase in the coming years, providing a valuable channel for Waldencast. Timeline: Ongoing.
- Geographic Expansion into Emerging Markets: Expanding into new geographic markets, particularly in Asia and Latin America, can drive revenue growth and diversify Waldencast's customer base. These regions have a growing demand for advanced skincare products and a rising middle class with increased disposable income. The Asia-Pacific skincare market is expected to be the fastest-growing region in the coming years, offering significant opportunities for Waldencast. Timeline: 2027-2030.
- Subscription-Based Business Model: Implementing a subscription-based business model can generate recurring revenue and improve customer retention. Offering customized skincare regimens and automatic product refills can enhance customer loyalty and drive long-term growth. The subscription e-commerce market is experiencing rapid growth, with consumers increasingly opting for convenient and personalized shopping experiences. Timeline: 2027.
What Are WALDU's Competitive Advantages?
- Established brands: Obagi Medical and Obagi Clinical have strong brand recognition.
- Professional distribution network: Products are primarily available through dermatologists and medical spas.
- Scientifically-backed formulations: Focus on advanced and effective skincare ingredients.
What Does WALDU Do?
Founded in 1988 and based in White Plains, New York, Waldencast plc is a skin care company specializing in advanced skin care treatments. The company's portfolio includes Obagi Medical, which offers transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles, and protect and enhance skin tone and texture. Additionally, Obagi Clinical provides skin care products designed to prevent the early signs of skin aging. These products are primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals, ensuring a targeted distribution strategy. Waldencast's focus on scientifically-backed formulations and professional channels differentiates it within the broader skincare market, emphasizing efficacy and dermatologist recommendation. The company aims to provide comprehensive solutions for various skin concerns, leveraging its established brands to maintain a competitive edge.
What Products and Services Does WALDU Offer?
- Provides advanced skin care treatments.
- Offers products designed to minimize the appearance of premature skin aging.
- Addresses skin damage, hyperpigmentation, acne, and sun damage.
- Offers products through dermatologists, plastic surgeons, medical spas, and other skin care professionals.
- Provides transformational skin care products formulated to minimize signs of skin aging.
- Addresses dark spots, hyperpigmentation, fine lines, and wrinkles.
- Protects and enhances skin tone and texture.
- Offers skin care products designed to prevent the early signs of skin aging.
How Does WALDU Make Money?
- Develops and markets advanced skincare products.
- Distributes products through professional channels such as dermatologists and medical spas.
- Generates revenue through the sale of skincare products to consumers.
What Industry Does WALDU Operate In?
Waldencast plc operates within the competitive skincare industry, which is characterized by continuous innovation and evolving consumer preferences. The market is driven by increasing demand for anti-aging products and advanced skincare solutions. Key trends include the rise of cosmeceuticals and the growing influence of digital marketing. Waldencast's focus on dermatologist-recommended products positions it within the professional skincare segment, competing with both established brands and emerging players. The company's success depends on its ability to differentiate its products and effectively reach its target market.
Who Are WALDU's Key Customers?
- Individuals seeking advanced skincare treatments.
- Patients of dermatologists and plastic surgeons.
- Clients of medical spas and other skin care professionals.
Key Financial Metrics
Return on equity for Waldencast plc stands at -6.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -4.3%, showing how much profit it generates from its asset base. A current ratio of 1.35 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -4.3%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Waldencast plc operates in the Software - Application industry within the Technology sector. It is headquartered in White Plains, US. The company is led by CEO Felipe Dutra. WALDU has traded publicly since 2021.
WALDU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests strong confidence in Waldencast's future, indicating that key stakeholders believe in the company's growth potential.
- Community sentiment has become increasingly positive, with discussions highlighting the company's innovative approach to sustainability and health-focused products.
- Waldencast's strategic partnerships with established brands have bolstered its market presence, enhancing its credibility in the competitive landscape.
- The growing consumer trend towards eco-friendly products aligns well with Waldencast's mission, potentially driving increased demand and brand loyalty.
Bear Case
- Concerns about market competition have surfaced, with some analysts questioning whether Waldencast can maintain its edge against larger, established players.
- Recent social sentiment has shown some skepticism, particularly regarding the company's ability to scale operations effectively without compromising quality.
- There are ongoing debates within the community about the sustainability of Waldencast's business model in a rapidly changing market environment.
- Regulatory challenges in the health and wellness sector could pose risks to Waldencast's operations, leading to potential delays in product launches.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
WALDU Latest News
No recent news available for WALDU.
Leadership: Felipe Dutra
CEO title
Felipe Dutra is the CEO of Waldencast plc. His background includes extensive experience in finance and management. Prior to joining Waldencast, Dutra held leadership positions at Anheuser-Busch InBev, where he served as the Chief Financial Officer. His responsibilities included overseeing financial planning, reporting, and investor relations. Dutra's expertise in financial strategy and operational efficiency is expected to drive Waldencast's growth and profitability.
Track Record: Under Felipe Dutra's leadership, Waldencast plc is focused on expanding its market presence and improving its financial performance. Key initiatives include streamlining operations, investing in product innovation, and strengthening relationships with key distribution partners. Dutra's strategic decisions are aimed at driving long-term growth and creating value for shareholders.
Waldencast plc Technology Stock: Key Questions Answered
What happened to Waldencast plc (WALDU) stock?
Waldencast plc (WALDU) no longer trades on public markets. It was delisted in July 2022. The figures below are historical and are not a current quote.
Can I still buy WALDU shares?
No. WALDU stopped trading on public markets in July 2022, so the shares are not available through a broker. Anything you see quoted for WALDU elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before WALDU stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Waldencast plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Waldencast plc do?
Waldencast plc is a skin care company that develops, markets, and distributes advanced skin care treatments. Its portfolio includes Obagi Medical and Obagi Clinical, which offer products designed to minimize signs of skin aging, address hyperpigmentation, and protect skin from damage.
What are the main risks for WALDU?
The main risks for Waldencast plc include intense competition in the skincare industry, which could impact market share and profitability. Economic downturns could reduce consumer spending on discretionary items like skincare products. The company's negative profit margin poses a risk to financial stability. Regulatory changes in the skincare industry could impact product development and marketing. Investors should carefully consider these risks before investing in WALDU.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Analyst consensus is pending further financial data and strategic developments.